Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48

Tian Yu Yang, Yimin Sun, Alan Norman Langnas, Yong Zhao

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Ly49A receptors expressed on NK, NKT, and T cells play inhibitory roles in regulating the immune responses in vivo and in vitro. Whether or not injection of anti-Ly49A monoclonal antibody (mAb) YE1/48 can block allograft rejection has not been evaluated. Balb/c mouse recipients received intraperitoneal injections of YE1/48 mAb (0.5 mg) or control mAb or phosphate-buffered saline on days -1 and 10. On day 0, fully MHC-mismatched allogeneic C57BL/6 (B6) skin grafts were implanted. The skin graft survival and anti-donor humoral responses were observed. Whereas allogeneic B6 skin grafts survived 14 days in isotopy control antibody-treated or nontreated Balb/c mice, injection of YE1/48 mAb significantly prolonged B6 skin graft survival to 19 days (P < 0.0005). Injection of YE1/48 mAb into presensitized Balb/c recipients did not significantly delay B6 skin graft rejection. On the other hand, after depleting recipient NK, NKT, and some cytotoxic T cells by injection of anti-asialo GM1, YE1/48 failed to prolong B6 skin graft survival in Balb/c recipients. The present studies indicate that injection of YE1/48 mAb significantly delays allogeneic skin graft rejection in nonsensitized recipients but not in sensitized recipients. The presence of NK, NKT cells, and some cytotoxic T cells may be essential for YE1/48-mediated immunosuppression in vivo.

Original languageEnglish (US)
Pages (from-to)148-154
Number of pages7
JournalClinical Immunology
Volume106
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Graft Survival
Monoclonal Antibodies
Skin
Injections
Natural Killer T-Cells
Graft Rejection
T-Lymphocytes
Natural Killer Cells
Transplants
Intraperitoneal Injections
Immunosuppression
Allografts
Phosphates
Antibodies

Keywords

  • Graft
  • Immune response
  • Transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48. / Yang, Tian Yu; Sun, Yimin; Langnas, Alan Norman; Zhao, Yong.

In: Clinical Immunology, Vol. 106, No. 2, 01.02.2003, p. 148-154.

Research output: Contribution to journalArticle

@article{0679363575c6457aa065ab30987816ee,
title = "Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48",
abstract = "Ly49A receptors expressed on NK, NKT, and T cells play inhibitory roles in regulating the immune responses in vivo and in vitro. Whether or not injection of anti-Ly49A monoclonal antibody (mAb) YE1/48 can block allograft rejection has not been evaluated. Balb/c mouse recipients received intraperitoneal injections of YE1/48 mAb (0.5 mg) or control mAb or phosphate-buffered saline on days -1 and 10. On day 0, fully MHC-mismatched allogeneic C57BL/6 (B6) skin grafts were implanted. The skin graft survival and anti-donor humoral responses were observed. Whereas allogeneic B6 skin grafts survived 14 days in isotopy control antibody-treated or nontreated Balb/c mice, injection of YE1/48 mAb significantly prolonged B6 skin graft survival to 19 days (P < 0.0005). Injection of YE1/48 mAb into presensitized Balb/c recipients did not significantly delay B6 skin graft rejection. On the other hand, after depleting recipient NK, NKT, and some cytotoxic T cells by injection of anti-asialo GM1, YE1/48 failed to prolong B6 skin graft survival in Balb/c recipients. The present studies indicate that injection of YE1/48 mAb significantly delays allogeneic skin graft rejection in nonsensitized recipients but not in sensitized recipients. The presence of NK, NKT cells, and some cytotoxic T cells may be essential for YE1/48-mediated immunosuppression in vivo.",
keywords = "Graft, Immune response, Transplantation",
author = "Yang, {Tian Yu} and Yimin Sun and Langnas, {Alan Norman} and Yong Zhao",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S1521-6616(02)00041-4",
language = "English (US)",
volume = "106",
pages = "148--154",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48

AU - Yang, Tian Yu

AU - Sun, Yimin

AU - Langnas, Alan Norman

AU - Zhao, Yong

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Ly49A receptors expressed on NK, NKT, and T cells play inhibitory roles in regulating the immune responses in vivo and in vitro. Whether or not injection of anti-Ly49A monoclonal antibody (mAb) YE1/48 can block allograft rejection has not been evaluated. Balb/c mouse recipients received intraperitoneal injections of YE1/48 mAb (0.5 mg) or control mAb or phosphate-buffered saline on days -1 and 10. On day 0, fully MHC-mismatched allogeneic C57BL/6 (B6) skin grafts were implanted. The skin graft survival and anti-donor humoral responses were observed. Whereas allogeneic B6 skin grafts survived 14 days in isotopy control antibody-treated or nontreated Balb/c mice, injection of YE1/48 mAb significantly prolonged B6 skin graft survival to 19 days (P < 0.0005). Injection of YE1/48 mAb into presensitized Balb/c recipients did not significantly delay B6 skin graft rejection. On the other hand, after depleting recipient NK, NKT, and some cytotoxic T cells by injection of anti-asialo GM1, YE1/48 failed to prolong B6 skin graft survival in Balb/c recipients. The present studies indicate that injection of YE1/48 mAb significantly delays allogeneic skin graft rejection in nonsensitized recipients but not in sensitized recipients. The presence of NK, NKT cells, and some cytotoxic T cells may be essential for YE1/48-mediated immunosuppression in vivo.

AB - Ly49A receptors expressed on NK, NKT, and T cells play inhibitory roles in regulating the immune responses in vivo and in vitro. Whether or not injection of anti-Ly49A monoclonal antibody (mAb) YE1/48 can block allograft rejection has not been evaluated. Balb/c mouse recipients received intraperitoneal injections of YE1/48 mAb (0.5 mg) or control mAb or phosphate-buffered saline on days -1 and 10. On day 0, fully MHC-mismatched allogeneic C57BL/6 (B6) skin grafts were implanted. The skin graft survival and anti-donor humoral responses were observed. Whereas allogeneic B6 skin grafts survived 14 days in isotopy control antibody-treated or nontreated Balb/c mice, injection of YE1/48 mAb significantly prolonged B6 skin graft survival to 19 days (P < 0.0005). Injection of YE1/48 mAb into presensitized Balb/c recipients did not significantly delay B6 skin graft rejection. On the other hand, after depleting recipient NK, NKT, and some cytotoxic T cells by injection of anti-asialo GM1, YE1/48 failed to prolong B6 skin graft survival in Balb/c recipients. The present studies indicate that injection of YE1/48 mAb significantly delays allogeneic skin graft rejection in nonsensitized recipients but not in sensitized recipients. The presence of NK, NKT cells, and some cytotoxic T cells may be essential for YE1/48-mediated immunosuppression in vivo.

KW - Graft

KW - Immune response

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0037301527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037301527&partnerID=8YFLogxK

U2 - 10.1016/S1521-6616(02)00041-4

DO - 10.1016/S1521-6616(02)00041-4

M3 - Article

C2 - 12672405

AN - SCOPUS:0037301527

VL - 106

SP - 148

EP - 154

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -